Call to Submit Abstracts for South African Palliative Care Conference in April 2023

Categories: Community Engagement.

The South African Palliative Care Conference in 2023 is a first-of-its-kind collaboration between the three leading palliative care organisations in our country, the Association of Palliative Care Practitioners of South Africa (PALPRAC), Palliative Care for Children South Africa (PatchSA) and the Hospice Palliative Care Association of South Africa (HPCA).This in-person conference will take place from 26 – 29 April 2023 at the world-class Vineyard Hotel in the beautiful mother city of Cape Town.

The conference aims to reach out to and to welcome people from a broad diversity of vocations whose work brings them in contact with adults, adolescents, and/or children with life-threatening and life-limiting conditions and to encourage the exciting exchange of knowledge, new and innovative ideas, research and experiences. The overriding focus of the workshops, plenary and parallel presentations at the conference will be on the imperative for palliative care of the future to be inclusive, relevant, and sustainable.

In the wake of a deadly pandemic which exposed the lack of preparedness of many healthcare providers to offer appropriate end-of-life care to patients and families and addressing the urgent need to raise awareness of the multiple benefits of early referral to palliative care, the compelling theme chosen for our conference is Palliative Care is Everyone’s Business.

We are pleased to let you know that the organisers have opened abstract submission for the South African Palliative Care Conference 2023 (#SAPCC23). The timelines are:

Abstract Deadlines

  • Call for Abstracts:
    1 September 2022
  • Submission deadline:
    1 November 2022
  • Final acceptance notification (feedback):
    15 December 2022
  • Presenting Author registration deadline:
    20 March 2023

The criteria for submission is:

  • The abstract text cannot exceed 2000 characters (including spaces, excluding title and authors).
  • Abstracts must be written in English, explained abbreviations may be used.
  • The number of authors should not exceed eight.
  • References are not required. If supplied, they are included in the character count.
  • Generic drug names should be preferred. The use of trade names is discouraged and should only be used when necessary.
  • Only one table may be included per abstract.
  • Preference will be given to abstracts that have not been published at a previous national or international conference.
  • To avoid issues with copyright, your abstract may not have been published previously in any international or national journal.


Visit for more information on the conference and to submit your abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *